Sharon Wrobel

About the Author Sharon Wrobel


Gilead To Acquire Stake in Cancer Drug Developer Pionyr For $275 Million

Gilead Sciences Inc. (GILD) announced on Tuesday that it will buy a 49.

Canadian Cannabis Producer Aurora Cannabis Plans Job Cuts, Closure of 5 Plants

Aurora Cannabis Inc. (ACB) on Tuesday announced plans to cut jobs and close five of its plants as it grapples with the financial …

J&J Fails To Overturn Baby Powder Verdict, Damages Cut To $2.12B

Johnson & Johnson’s (JNJ) bid to toss out a jury verdict in favor of women who blamed their ovarian cancer on its baby …

Mastercard Buys Finicity For $825 Million; Top Analyst Cuts Rating

Mastercard Inc. (MA) said on Tuesday that it entered into an agreement to buy financial data firm Finicity for $825 million.

Check Point Teams Up With Coursera For Cybersecurity Education Program

Check Point Software Technologies Ltd. (CHKP) has entered into a partnership with online learning platform Coursera to offer free cybersecurity courses as the …

Lyft Agrees To Pay Damages, Revise Wheelchair Policy In Settlement Agreement

Ride-hailing company Lyft Inc. (LYFT) has reached a settlement agreement over allegations that some of its drivers denied rides to people using a …

Microsoft’s Xbox Closes Mixer Live Streaming, Partners With Facebook Gaming

Microsoft Corp’s (MSFT) Xbox division has decided to shut down down its Mixer operations, a live streaming tool for games, and instead has …

Apyx Spikes 45% In Pre-Market On Nod To Sell Helium Products In New Countries

Shares in Apyx Medical Corp. (APYX) spiked 45% in pre-market trading after the medical devices manufacturer won regulatory approval to sell its Helium …

Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End

Gilead Sciences Inc. (GILD) said it expects to produce more than 2 million treatment courses of its experimental coronavirus drug candidate remdesivir by …

TripAdvisor Warns Of ‘Materially Worse’ Revenue Performance in Q2; Shares Drop 5%

TripAdvisor (TRIP) said on Monday that it is expecting second-quarter revenue year-on-year performance to be “materially worse” than in the previous quarter sending …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts